EGFR inhibitor-associated acneiform folliculitis: assessment and management

American Journal of Clinical Dermatology
Madeleine Duvic

Abstract

Treatment with epidermal growth factor receptor (EGFR) inhibitors is associated with cutaneous adverse events, including acneiform folliculitis, dry skin, and nail disorders. Acneiform folliculitis is a class effect of EGFR inhibitors that is thought to be a direct result of EGFR blockade in the hair follicle. The folliculitis is typically mild to moderate in severity and reversible without scarring upon treatment completion. Dose modification or treatment discontinuation is rarely necessary, except in severe cases. Standard acne treatments (e.g. benzoyl peroxide, oral or topical antibacterials, retinoic acid) may provide some benefit, based on anecdotal reports. Clinicians should be aware of the possibility of superinfection with Staphylococcus aureus, in some cases involving meticillin-resistant strains, which may require treatment with oral antibacterials. Further study is needed to determine how the presence and severity of acneiform folliculitis are related to clinical outcomes, and which patients taking EGFR inhibitors are more likely to develop this disorder.

References

Jun 11, 1990·The Journal of Investigative Dermatology·L B NanneyK A Holbrook
Jan 13, 1995·Cell·P H JonesF M Watt
Dec 24, 1997·The Journal of Investigative Dermatology·D PeusM R Pittelkow
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HidalgoE K Rowinsky
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan AlbanellJose Baselga
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm RansonEric K Rowinsky
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstPatricia Mucci LoRusso
Aug 6, 2003·Acta Oncologica·Svein DuelandKjell Magne Tveit
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Denis SoulieresLillian L Siu
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Udo VanhoeferJosé Baselga
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lijo SimpsonAgnes Piotrowski
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzRobert J Mayer
Jun 24, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric K RowinskyJanice Dutcher
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Jul 24, 2004·The British Journal of Dermatology·T Leivo, H Heikkilä
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Román Pérez-SolerPhilip Bonomi
Jan 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ki Young ChungLeonard B Saltz
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Román Peréz-Soler, Leonard Saltz
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Nov 1, 1990·The Journal of Investigative Dermatology·L E KingL B Nanney

❮ Previous
Next ❯

Citations

Apr 28, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Z ReguiaiO Bouché
Jul 5, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D E PetersonUNKNOWN ESMO Guidelines Committee
Feb 1, 2011·Clinical Journal of Oncology Nursing·Kathryn J WhiteKathleen Scott
Jun 16, 2012·Dermatology : International Journal for Clinical and Investigative Dermatology·Vasiliki NikolaouKostas N Syrigos
Mar 2, 2017·American Journal of Clinical Dermatology·Priyanka VedakDaniela Kroshinsky
Feb 3, 2015·The British Journal of Dermatology·E M Kuiper, S H Kardaun
Jan 7, 2020·International Journal of Dermatology·Katrina H LeeNatasha A Mesinkovska
Oct 15, 2010·Anais Brasileiros De Dermatologia·Jose Antonio Sanches JuniorPaulo Ricardo Criado
Aug 5, 2021·International Journal of Colorectal Disease·Ken NakataUNKNOWN Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO)
Nov 26, 2009·The Medical Clinics of North America·Margarita S LolisAlan R Shalita

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved